Spire Healthcare to Be Taken Private in £1 Billion Deal

Spire Healthcare, a private hospital company in the United Kingdom, has agreed to be bought by a group of investment firms for about £1 billion. The buyers have formed a new company called Tulip UK to complete the purchase. Tulip UK is made up of funds managed by three firms: Toscafund Asset Management, THCP Advisory, and Ares Management. If the deal goes through, Spire will leave the London stock market and become a privately owned company.

Spire currently runs 38 hospitals and around 55 clinics across England, Wales, and Scotland. It also operates a network of private doctors and provides health services to more than 1,400 employers. This makes Spire one of the largest private healthcare providers in the UK. Many people rely on its services for medical care outside of the National Health Service.

Under the terms of the deal, Spire's shareholders are being offered 250 pence for each share they own. That price is about 66% higher than what the shares were worth on May 13, the last trading day before the takeover talks became public. A higher-than-market price like this is called a premium, and it is meant to encourage shareholders to agree to the sale. The total value of the deal comes to roughly £1.03 billion.

The buyers said they believe Spire will do better as a private company than as one listed on the stock market. Spire's leaders said the company has been dealing with rising costs, including higher national insurance payments and a higher minimum wage. They also said that investor interest in UK public markets has been low lately. Moving into private ownership, they believe, will give Spire better access to money needed for future growth.

Spire has been going through a strategic review — a careful look at its plans and goals — since last September. After the deal is complete, the new owners plan to carry out another year-long review. This review may lead to changes in some parts of Spire's business, including its private doctor network. There is a chance that some jobs in that network could be cut if the new owners decide to sell off parts of that business.

There will also be a change in leadership at Spire. Chief executive Justin Ash will step down from his role and be replaced on a temporary basis by Sir David Sloman. Debbie White, who is set to become Spire's chair, said the board believes this deal is the best outcome for shareholders. Martin Hughes of Toscafund said the move will give Spire more freedom to invest in its hospitals, use new technology, and set higher standards in patient care.